Clinical Guides
Dupuytren's Contracture
A clinically focused guide to Dupuytren disease and established finger contracture, covering clinical staging, functional decisions, recurrence and procedural safeguards for Indian practice.
MedNext Academy | 15 min read
Dupuytren's Contracture
A clinically focused guide to Dupuytren disease and established finger contracture, covering clinical staging, functional decisions, recurrence and procedural safeguards for Indian practice.
Summary
Dupuytren disease is a benign fibroproliferative disorder of the palmar and digital fascia. It often begins as a firm palmar nodule or skin pit and may develop into a longitudinal cord that progressively limits finger extension. The ring and little fingers are commonly affected, although any digit and the first web space can be involved. A nodule without loss of extension is disease but not yet a contracture. The distinction matters because many nodules remain mild, no current intervention eradicates the underlying tendency, and treatment is directed at meaningful contracture and function rather than the mere presence of a lump.
Diagnosis is clinical. History establishes rate of progression, tasks impaired, previous treatment, bilateral disease and associated risk factors. Examination maps nodules and cords, measures passive extension deficit at each joint, assesses skin and neurovascular status, and uses the tabletop test as a practical functional screen. Imaging is not routine for a typical presentation. Trigger finger, flexor tendon injury, joint contracture, post-traumatic scar, ulnar neuropathy and a solid mass must be considered when the pattern is atypical. Sudden painful inflammation or rapid progression is not the usual natural history.
Observation with serial measurement is appropriate for early disease without functional limitation. Established contracture can be released by percutaneous needle fasciotomy or treated with limited fasciectomy; dermofasciectomy and salvage procedures are reserved for selected severe or recurrent patterns. Less invasive release generally permits faster recovery but has a higher recurrence burden. Surgery offers more durable correction for many patients but entails wound, scar, stiffness, tendon, nerve, vessel and complex regional pain risks. Radiotherapy, collagenase and primary splinting have jurisdiction-specific availability and uncertain or limited evidence; none should be marketed as a cure. This draft is has been reviewed by the MedNext Clinical Team and remains reviewed.
How Common Is It?
Dupuytren disease is strongly associated with ancestry, age and how disease is defined. BSSH describes it as common in middle and later life and more frequent in men than women, particularly in populations of Northern European heritage. Studies that count a single palmar nodule produce higher prevalence than studies requiring a measurable digital contracture. Community surveys, diabetes clinics and hand-surgery registries therefore answer different questions. Bilateral changes are common, but severity may be asymmetric. Most affected people do not progress at the same rate, and referral cohorts overrepresent disabling or recurrent disease.
The condition is reported less often in many South Asian populations than in Northern European cohorts, but this comparison is vulnerable to under-recognition, different ancestry, referral access and small samples. India has enormous genetic and demographic diversity, and no representative contemporary national survey was identified in the sources used here. A figure from one hospital, occupational group or region should not be transformed into an Indian prevalence. Likewise, the BSSH estimate that roughly one in three people with nodules develop cords reflects its patient information synthesis, not a precise individual forecast.
Clinical burden is better described through extension deficit, affected joints, progression, dominant-hand involvement and task limitation than through prevalence alone. Metacarpophalangeal contracture can impair hand placement; proximal interphalangeal contracture is often harder to correct completely and may cause more persistent disability. Local audit should record age, sex, family history, diabetes, tobacco and alcohol exposure, bilateral or ectopic disease, joint angles, intervention, complications, patient-reported function and recurrence at explicit intervals. Case counts without the screened population and disease definition cannot estimate risk. The honest conclusion for Indian counselling is that the disease exists across populations, but local probability and natural history remain incompletely quantified.
Risk Factors
Increasing age, male sex and family history are the most consistently recognized associations. BSSH notes greater frequency in Northern European populations and familial clustering. A strong diathesis may include younger onset, bilateral disease, multiple affected rays, recurrence and ectopic fibromatosis such as knuckle pads or plantar nodules. These features can suggest more aggressive biology but do not determine an individual outcome. The disease should not be attributed to manual labour: current patient guidance does not support ordinary hand work as a cause, even though a contracture can become more noticeable during gripping tasks.
Diabetes, smoking and high alcohol consumption are associated with Dupuytren disease, and epilepsy has also been reported. Association does not mean that every affected patient has these exposures or that removing one factor reverses a cord. Ask about medicines only to understand comorbidity, perioperative planning and possible alternative diagnoses; do not repeat the outdated assumption that antiepileptic treatment alone explains the condition. Trauma or surgery sometimes precedes recognition, but temporal proximity cannot establish causation. A patient should not be blamed for disease progression.
Risk factors for treatment complications and recurrence are separate from risk of developing disease. Smoking, diabetes, immunosuppression, anticoagulation and a vascularly compromised hand can worsen wound or perioperative risk and require optimization. Severe proximal interphalangeal involvement, recurrent disease, adherent skin and prior surgery make correction technically harder. Younger patients with a marked diathesis may recur over a longer lifetime. Neurovascular structures can be displaced by spiral cords, which increases procedural danger. The Dutch guideline recommends reconsidering surgery in several relative-risk settings, not imposing automatic exclusion. Decisions should balance function, trajectory, tissue anatomy, health, recovery capacity and patient preference.
Diagnosis
History
Ask when the patient first noticed a nodule, skin pit, cord or inability to straighten a finger and how it has changed over months or years. Identify impaired tasks such as placing the hand flat, washing the face, wearing gloves, using tools, keyboarding, prayer positions or reaching into a pocket. Record pain, locking, trauma, previous injection, needle release or surgery, postoperative therapy and recurrence. Explore family history, diabetes, smoking, alcohol, epilepsy, vascular disease, medicines and similar nodules on the other hand, knuckles, feet or penis. Rapid growth, systemic illness or neurological symptoms suggest another process.
Examination
Inspect both hands with the palms flat and fingers extended. Map skin pits, nodules and cords and identify the affected ray. Palpate whether a cord becomes tense with attempted extension; distinguish it from a flexor tendon. Measure passive extension deficit at the metacarpophalangeal and proximal and distal interphalangeal joints separately, ideally with a goniometer, and record flexion, grip and task-specific function. The tabletop test is positive when the palm and fingers cannot lie flat, but treatment is not decided by that test alone. Check sensation, perfusion, tendon integrity, joint stiffness, trigger phenomena and cervical or ulnar nerve findings.
Investigations
Typical Dupuytren disease needs no routine blood test, radiograph, ultrasound or MRI. Tests are selected for an alternative diagnosis or comorbidity, not to confirm every palpable cord. Radiographs may assess osteoarthritis, prior fracture or a fixed joint; ultrasound can characterize an uncertain superficial mass or tendon relation; MRI is exceptional. Before a procedure, document baseline joint angles, skin quality, sensation and vascular status, and follow local anaesthetic and perioperative assessment policy. Biopsy is not routine. Atypical rapid growth, a discrete solid mass or destructive finding requires specialist evaluation rather than a presumptive release.
Differential Diagnosis
Trigger finger causes painful catching or locking from flexor tendon-sheath disease, often with a tender A1 pulley nodule; the finger can usually be passively corrected between episodes until secondary stiffness develops. A Dupuytren cord lies in palmar fascia, is associated with skin pitting and creates a persistent extension deficit. Flexor tendon rupture impairs active flexion rather than passive extension and may follow injury or inflammatory disease. Post-traumatic or postoperative scar contracture has a different history and distribution. Volkmann contracture, burns and spasticity produce broader patterns and require separate pathways.
Joint pathology can mimic or add to a fascial contracture. Osteoarthritis, inflammatory arthritis, previous fracture-dislocation and prolonged immobilization may produce capsular stiffness. Examine whether restriction remains after relaxing the cord and whether radiographs show joint disease. Ulnar neuropathy can cause clawing, sensory change and intrinsic muscle weakness; it is not explained by a palmar cord. Camptodactyly and other congenital or developmental contractures typically present earlier. Diabetic cheiroarthropathy produces waxy thick skin and limited joint mobility, often affecting multiple digits without a discrete pretendinous cord.
A palmar ganglion, giant-cell tumour of tendon sheath, epidermoid cyst or another soft-tissue tumour can resemble an early nodule. A rapidly enlarging, unusually painful, fixed or neurologically symptomatic mass requires tumour-aware assessment. Ledderhose disease of plantar fascia and Peyronie disease are related ectopic fibromatoses rather than alternatives in the hand; knuckle pads can coexist. Complex regional pain syndrome is a possible complication after intervention and presents with disproportionate pain, sensory and autonomic change rather than primary cord formation. The diagnostic statement should specify disease stage and joint deficits, for example a ring-finger pretendinous cord with metacarpophalangeal and proximal interphalangeal contracture, instead of using the label alone.
Management
Early nodules without functional loss are observed. Explain that progression is variable, teach a simple tabletop check, photograph or measure extension with consent, and arrange review if loss of extension or task difficulty develops. Massage, stretching, ultrasound therapy, supplements and routine splints have not been shown to dissolve cords. The Dutch multidisciplinary guideline could not recommend primary non-invasive treatments as disease-modifying therapy. Maintaining comfortable hand use and managing comorbidity are reasonable, but repeated forceful stretching may cause pain without altering the fibrosis. Observation should be active and documented, not abandonment.
When contracture affects function or becomes clinically significant, discuss release options with a hand specialist. Percutaneous needle fasciotomy divides a palpable cord through small punctures under local anaesthesia and offers rapid recovery, but recurrence is common and the technique is inappropriate without a palpable strand. Current guidelines considers its safety and efficacy adequate when normal consent, audit and governance arrangements are used. Limited fasciectomy removes affected fascia through an open operation and is commonly selected for established primary disease. Dermofasciectomy removes involved skin and fascia with grafting in selected recurrence, adherent skin or aggressive disease.
Choice is not a contest between a universally better and worse procedure. Joint, cord, skin, previous surgery, age, diathesis, comorbidity, occupation, desired recovery and tolerance of recurrence all matter. Proximal interphalangeal correction can be incomplete even after technically successful release. The Dutch guideline recommends partial fasciectomy as first choice in its jurisdiction and selected needle fasciotomy for people accepting greater recurrence; other health systems may weight options differently. Collagenase availability and approval vary, and international guidelines withdrew its UK appraisal after the product became unavailable there. Radiotherapy for early disease lacks robust comparative evidence and should not be sold as established routine care. Long-term review addresses recurrence, extension loss and patient function.
Prescribing Information
There is no routine oral medicine that removes a Dupuytren cord or prevents recurrence. Analgesics are rarely needed for stable early disease because nodular tenderness often settles. If discomfort limits use, consider short-term paracetamol after checking liver disease, alcohol exposure, body weight and duplicate products. An NSAID may be appropriate for a separate inflammatory or postoperative pain indication but requires kidney, gastrointestinal, cardiovascular, anticoagulant and pregnancy review. Neither analgesic class modifies fibroproliferation. Long-term opioids and empirical systemic steroids are not appropriate treatment for uncomplicated contracture.
Collagenase clostridium histolyticum is an injected enzyme intended to disrupt a cord, not an ordinary office steroid injection. Availability, regulatory approval and supply differ by country; current guidelines' technology appraisal was withdrawn because the product was no longer available in the UK, and the Dutch guideline restricts it to clinical trials. Those positions cannot be converted into a claim about current Indian licensing or procurement without checking the applicable regulator and product information. Potential harms include bruising, swelling, skin tear, tendon injury, neurovascular injury and hypersensitivity, and manipulation is part of the protocol. It should never be improvised from non-approved preparations.
Peri-procedural prescribing belongs to the treating team. Local anaesthetic choice, antibiotic prophylaxis, anticoagulant management, postoperative analgesia and treatment of infection must follow current Indian institutional protocols and individual risks. Anticoagulants should not be stopped without coordination with the prescriber. Steroid injection into a painful nodule has limited evidence and risks skin atrophy and pigment change; it is not a cure for established contracture. Following a procedure, increasing pain, swelling, fever, wound drainage, sensory loss, colour change or inability to flex requires prompt assessment. This educational guide intentionally avoids doses and cannot replace a prescription.
When to Refer
Refer routinely to a hand-surgery service when a cord produces progressive extension loss, the tabletop test becomes positive, daily tasks are impaired, or the patient wants an informed discussion of release after understanding recurrence. Exact numerical thresholds vary across services and should not override function, joint pattern or progression. Proximal interphalangeal involvement deserves timely assessment because fixed contracture can become difficult to correct. Earlier referral is also reasonable for younger-onset aggressive disease, bilateral multiple-ray involvement, recurrent contracture or skin adherence, even if intervention is not immediately selected.
Use expedited referral when the diagnosis is uncertain, the lesion grows rapidly, there is a discrete atypical mass, tendon dysfunction, significant neurological deficit or vascular compromise. Sudden painful swelling, erythema or systemic illness is not normal progression and needs assessment for infection, crystal disease or another acute process. After needle or open treatment, new loss of active flexion, persistent numbness, poor perfusion, severe disproportionate pain, wound necrosis or infection requires urgent contact with the operating service. These features are about complications or alternative diagnoses, not routine recurrence.
A referral should include affected digits and joints, measured extension deficit, progression, functional limitations, tabletop-test result, skin quality, neurovascular findings, comorbidities, medicines, smoking, prior procedures and the patient's preference about recovery versus durability. Hand therapy may support postoperative wound, oedema, scar and motion management when the surgeon or therapist identifies a need; routine prolonged splinting for every patient is not evidence-neutral. Rheumatology referral is useful when inflammatory polyarthritis or another systemic disorder better explains hand stiffness. The specialist consultation should preserve shared decision-making and may reasonably conclude that continued observation is best.
Red Flags
Dupuytren disease usually progresses slowly over months or years. Rapid enlargement over days or weeks, marked rest pain, warmth, erythema, fever, drainage or constitutional illness should not be attributed to ordinary cord progression. Consider infection, inflammatory disease, haemorrhage or tumour. A solitary deep fixed mass, ulceration, unexplained night pain or neurological deficit also requires diagnostic reconsideration. Even when a patient has known Dupuytren disease, a new lump may be a separate condition. Familiarity with the diagnosis must not prevent assessment of a changing lesion.
Neurovascular findings are especially important before and after intervention. New numbness, dysaesthesia, motor weakness, a cold or pale digit, delayed capillary refill or severe swelling requires prompt review. Spiral cords can displace digital nerves and arteries, making recurrent or severe disease anatomically hazardous. After a needle procedure, inability to actively flex a finger raises concern for tendon injury; after open surgery, bleeding, wound separation, infection, skin necrosis and severe stiffness require communication with the surgical team. Disproportionate pain with swelling, colour or temperature change and allodynia may signal complex regional pain syndrome.
A fixed finger can interfere with hygiene and produce pressure injury, especially in frailty, neurological disease or diabetes. Maceration, ulceration or recurrent skin infection in the palm is a reason for timely assessment rather than waiting for a routine annual review. Trauma to a contracted finger can cause fracture, dislocation or tendon injury and should be evaluated on its own merits. Safety-netting should name the expected course and the exceptions: gradual painless change can await planned review, but acute inflammatory, neurovascular, tendon or wound problems cannot. A reassuring label never substitutes for post-procedure follow-up responsibility.
Indian Clinical Context
Dupuytren disease may be less familiar to some Indian primary-care clinicians because commonly quoted prevalence derives from Northern European populations. Under-recognition is possible, while indiscriminate application of foreign rates is equally misleading. India lacks a representative national registry for nodules, contracture severity, procedures and recurrence. Clinical assessment is inexpensive and usually sufficient: map cords, measure each joint and document function. Routine MRI adds cost without improving a typical diagnosis. Referral pathways may lead to plastic surgery, orthopaedics or a dedicated hand unit depending on the institution.
Occupation, travel and out-of-pocket payment shape procedural choices. Needle fasciotomy may appeal because recovery is faster, but access to trained operators and the likelihood of recurrence must be discussed. Open fasciectomy may provide more durable correction but brings a longer wound and rehabilitation period. A farmer, driver, surgeon, musician or daily-wage worker may value different outcomes. Consent should be available in an understood language and should state that correction may be incomplete, disease can recur and a procedure can injure tendon, nerve, artery or skin. Marketing claims of permanent cure are false.
The Dutch, current guidelines, public health and BSSH materials arise from European health systems with different population ancestry, funding, waiting times, collagenase availability and radiotherapy practice. They provide useful evidence and safety principles but are not Indian legal or regulatory instructions. Before offering collagenase or radiotherapy, verify current Indian authorization, product availability, specialist governance and evidence; do not infer approval from foreign historical guidance. Diabetes and tobacco exposure deserve optimization because they affect health and procedural risk, not because lifestyle change is guaranteed to reverse disease. This guide is educational and jurisdiction-limited. Local protocol, trained hand expertise and a named clinician responsible for follow-up remain essential.
NMC Competency Mapping
The NMC 2024 curriculum supports Dupuytren learning through integrated outcomes rather than a dedicated named algorithm. Anatomy of palmar fascia, flexor tendons, digital nerves, arteries and hand joints provides the basis for understanding cords and procedural risk. Orthopaedics OR1.3 requires learners to describe the aetiopathogenesis, clinical features, investigations and management principles of soft-tissue injury, while Surgery SU17.7 covers corresponding clinical recognition and management principles. Medicine and surgery teaching also support diabetes, tobacco and perioperative risk assessment. Faculties should verify the exact volume and code wording used locally.
A safe undergraduate should distinguish a nodule from a cord and established contracture, identify common rays, measure metacarpophalangeal and interphalangeal extension loss and perform the tabletop test. They should assess tendon function and neurovascular status, formulate alternatives such as trigger finger, joint stiffness and ulnar clawing, and explain why routine imaging is unnecessary in a typical case. Counselling should cover variable progression, lack of a cure, recurrence and the balance between faster minimally invasive recovery and more extensive surgery.
Competency mapping does not authorize needle fasciotomy, collagenase injection or fasciectomy. These require supervised specialist training, consent, anatomical expertise, sterile systems and complication management. Suitable examination stations include recognizing a pretendinous cord, separating active from passive deficit, counselling observation and identifying post-procedure tendon or vascular injury. Exam-focused teaching should not reduce management to a single angle threshold or operation name. The clinically defensible sequence is disease stage, objective joint deficit, patient function, progression, shared decision and safe referral.
Key Exam Pearls for NEET PG
Dupuytren disease is fibroproliferation of palmar and digital fascia, not flexor tendon shortening. Palmar nodules and pits may develop into cords that flex the fingers, most often the ring and little fingers. Disease may be bilateral and can coexist with Garrod knuckle pads, plantar fibromatosis or Peyronie disease. Recognized associations include increasing age, male sex, family history, Northern European ancestry, diabetes, smoking and heavy alcohol exposure. Manual labour is not established as the cause. The condition usually progresses slowly and may never create significant contracture.
Diagnosis is clinical. Measure passive extension deficit separately at the metacarpophalangeal and proximal interphalangeal joints and document a tabletop test. Imaging is unnecessary for a typical cord. Trigger finger produces catching at the A1 pulley; ulnar palsy adds sensory and intrinsic motor findings; joint disease restricts motion without the characteristic fascial cord. A rapidly growing painful mass or acute inflamed hand is not routine Dupuytren disease. Proximal interphalangeal contracture is often harder to correct completely than metacarpophalangeal disease.
Observe early disease without functional limitation. Percutaneous needle fasciotomy divides a palpable cord, allows rapid recovery and has a higher recurrence burden; it is not used when no strand is palpable. Limited fasciectomy removes affected fascia and is a common operation for established disease. Dermofasciectomy is considered for selected recurrent, skin-involved or aggressive cases. No procedure removes the biological tendency, and full correction is not guaranteed. Consent includes recurrence, scar, stiffness, infection, tendon, nerve and vessel injury and complex regional pain. Primary splinting, radiotherapy and collagenase require evidence and jurisdiction caution. The exam-safe answer links intervention to functional contracture, not a painless nodule alone.
Frequently Asked Questions
Does a painless Dupuytren nodule need an operation before it becomes a cord?
Usually not. A nodule without extension loss or functional limitation can be observed because progression is variable and treatment does not eradicate the disease. Record the baseline, teach a tabletop check and arrange review if a cord, measurable contracture or task difficulty develops. Rapid or atypical change needs earlier reassessment.
Is needle fasciotomy better than limited fasciectomy for every patient?
No. Needle fasciotomy is less invasive and generally has faster recovery, but recurrence is more common and a palpable cord is required. Fasciectomy is more extensive and has wound and recovery burdens but may provide more durable correction. Joint involvement, skin, recurrence, health, goals and local expertise determine the choice.
Can hand exercises or a splint dissolve a Dupuytren cord?
Evidence does not show that primary exercises or splinting dissolve the fibrotic cord or reliably prevent progression. Comfortable hand use is reasonable, and selected postoperative therapy may address motion, swelling or scar. Forceful self-stretching can cause pain or injury and should not delay reassessment when extension loss is progressing.
Will a successfully treated finger remain straight permanently?
Not necessarily. A procedure can improve extension and function but cannot remove the underlying predisposition, so disease may recur in the treated ray or appear elsewhere. Correction may also be incomplete, especially at a longstanding proximal interphalangeal joint. Follow-up should distinguish recurrence from joint stiffness, scar and a new complication.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic